The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Src family kinases in tumor progression and metastasis
Abstract
The Src family of non-receptor protein tyrosine kinases plays critical roles in a variety of cellular signal transduction pathways, regulating such diverse processes as cell division, motility, adhesion, angiogenesis, and survival. Constitutively activated variants of Src family kinases, including the viral oncoproteins v-Src and v-Yes, are capable of inducing malignant transformation of a variety of cell types. Src family kinases, most notably although not exclusively c-Src, are frequently overexpressed and/or aberrantly activated in a variety of epithelial and non-epithelial cancers. Activation is very common in colorectal and breast cancers, and somewhat less frequent in melanomas, ovarian cancer, gastric cancer, head and neck cancers, pancreatic cancer, lung cancer, brain cancers, and blood cancers. Further, the extent of increased Src family activity often correlates with malignant potential and patient survival. Activation of Src family kinases in human cancers may occur through a variety of mechanisms and is frequently a critical event in tumor progression. Exactly how Src family kinases contribute to individual tumors remains to be defined completely, however they appear to be important for multiple aspects of tumor progression, including proliferation, disruption of cell/cell contacts, migration, invasiveness, resistance to apoptosis, and angiogenesis. This review details the evidence for Src family activation in human tumors, and emphasizes possible consequences to tumor progression. Given the ability of Src and its family members to participate in so many aspects of tumor progression and metastasis, Src family kinases are attractive targets for future anti-cancer therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SRC kinase, a cytoplasmic non-receptor tyrosine kinase, has been implicated in the development and progression of cancer [19–22].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [22]
In the citing paper
“In addition to MAPK, SRC kinases can directly modulate many downstream targets including and c-MYC [19, 21, 22, 44], related to drug resistance and tumor cell survival.”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [22]
Citations
Cites
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. Μ., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,537
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T. R., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,333
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,432
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 2×
“Through then very tedious molecular approaches, Bishop and Varmus [3] demonstrated that the viral Src gene (v-src) had as its progenitor a normal cellular gene (proto-oncogene) c-src, an experiment largely responsible for the awarding of the”
BackgroundRegulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,193
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,171
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.
Migliaccio, A., Domenico, M. D., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 950
Identification of a transformation-specific antigen induced by an avian sarcoma virus
Brugge, J. S., & Erikson, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 889
Role of Src expression and activation in human cancer
Irby, R., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 878
Cited by
Items 401–500 of 845
Pathways of metastasis suppression in bladder cancer
Said, N. A., & Theodorescu, D. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9197-4 · Cited by 29
Gao, Z., Zhao, G., Lv, Y., Peng, D.-B., Tang, X., Song, H., & Guo, Q. (2018) · Oncology Reports · doi:10.3892/or.2018.6827 · Cited by 29
Chao, C., Lee, W.-F., Wang, S., Chen, P., Yamamoto, A., Chang, T., Weng, S., & Liu, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16743 · Cited by 28
Gadducci, A., Biglia, N., Cosio, S., Sismondi, P., & Genazzani, A. R. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903056878 · Cited by 28
Small molecule tyrosine kinase inhibitors in pancreatic cancer
El‐Rayes, B. F. (2008) · Biologics · doi:10.2147/btt.s3003 · Cited by 28
Cancer Stem Cell–Suppressing Activity of Chrysotoxine, a Bibenzyl from Dendrobium pulchellum
Bhummaphan, N., Pongrakhananon, V., Sritularak, B., & Pithi Chanvorachote, B. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244467 · Cited by 28
Chen, J., Hung, C.-C., Huang, K., Chen, Y.-T., Liu, S.-Y., Chiang, W.-F., Chen, H.-R., Yen, C., Wu, Y.-J., Ko, J.-Y., et al. (2008) · Neoplasia · doi:10.1593/neo.08854 · Cited by 27
Quantitative mass spectrometry for colorectal cancer proteomics
Martínez‐Aguilar, J., Chik, J. H. L., Nicholson, J., Semaan, C., McKay, M. J., & Molloy, M. P. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200080 · Cited by 27
Gilani, R. A., Phadke, S., Bao, L., Lachacz, E. J., Dziubinski, M. L., Brandvold, K. R., Steffey, M. E., Kwarcinski, F. E., Graveel, C. R., Kidwell, K., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2158 · Cited by 27
RetractedEnomoto, M., Takemoto, D., & Igaki, T. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.07.002 · Cited by 29
Ju, H., Lim, B., Kim, M., Kim, Y. S., Kim, W. H., Ihm, C., Noh, S., Han, D. S., Yu, H.-J., Choi, B. Y., et al. (2009) · Neoplasia · doi:10.1593/neo.91132 · Cited by 27
Stegeman, H., Kaanders, J. H. A. M., Verheijen, M. M., Peeters, W. J. M., Wheeler, D. L., Iida, M., Grenman, R. A., van der Kogel, A. J., Span, P. N., & Bussink, J. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-133 · Cited by 27
Nourazarian, A., Najar, A. G., Farajnia, S., Khosroushahi, A. Y., Pashaei‐Asl, R., & Omidi, Y. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.9.4751 · Cited by 27
Stenzinger, A., Schreiner, D., Reiners-Koch, P.-S., Hofer, H. W., & Wimmer, M. A. (2009) · International review of cytology · doi:10.1016/s1937-6448(09)75006-3 · Cited by 28
Hirsch, C. L., Smith-Windsor, E., & Bonham, K. (2005) · International Journal of Cancer · doi:10.1002/ijc.21383 · Cited by 27
Welman, A., Cawthome, C., Ponce-Perez, L., Barraclough, J., Danson, S., Murray, S., Cummings, J., Allen, T. D., & Dive, C. (2006) · Neoplasia · doi:10.1593/neo.06475 · Cited by 26
Yuan, M., Xu, L.-F., Zhang, J., Kong, S.-Y., Wu, M., Lao, Y.-Z., Zhou, H., Zhang, L., & Xu, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00586 · Cited by 26
Carcinogenicity of nicotine and signal pathways in cancer progression: a review
Rao, Z., Xu, Y., He, Z., Wang, J., Ji, H., Zhang, Z., Zhou, J., Zhou, T., & Wang, H. (2023) · Environmental Chemistry Letters · doi:10.1007/s10311-023-01668-1 · Cited by 26
Huang, H., Ma, J., Shi, J., Meng, L., Jiang, H., Ding, J., & Liu, H. S. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.032 · Cited by 26
c- Src and its role in cystic fibrosis
Massip-Copiz, M. M., & Santa-Coloma, T. A. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.08.001 · Cited by 26
Osinalde, N., Aloria, K., Ibarra, M. J. O., & Kratchmarova, I. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.04.026 · Cited by 27
Kostrzewa, T., Wołosewicz, K., Jamrozik, M., Drzeżdżon, J., Siemińska, J., Jacewicz, D., Górska‐Ponikowska, M., Kołaczkowski, M., Łaźny, R., & Kuban‐Jankowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910368 · Cited by 26
Hong, K., Lee, J., Hong, S., & Hong, S. (2015) · Amino Acids · doi:10.1007/s00726-015-2070-6 · Cited by 26
Hamadi, A., Deramaudt, T. B., Takeda, K., & Rondé, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8424-4 · Cited by 26
Dong, S., Khoo, A., Wei, J., Bowser, R. K., Weathington, N. M., Xiao, S., Zhang, L., Ma, H., Zhao, Y., & Zhao, J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00132.2014 · Cited by 27
Thorn, C. C., Freeman, T. C., Scott, N., Guillou, P. J., & Jayne, D. G. (2008) · Gut · doi:10.1136/gut.2008.157255 · Cited by 27
van Zyp, J. V. D. V., Thamilselvan, V., Walsh, M. F., Polin, L., & Basson, M. D. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2004.07.005 · Cited by 28
Morrow, C. J., Ghattas, M. A., Smith, C. G., Bönisch, H., Bryce, R. A., Hickinson, D. M., Green, T. P., & Dive, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0694 · Cited by 26
Planas-Silva, M. D., & Hamilton, K. N. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0398-z · Cited by 26
Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer
Li, Y. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i8.239 · Cited by 27
Kumar, S., Lü, B., Davra, V., Hornbeck, P. V., Machida, K., & Birge, R. B. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0242 · Cited by 26
TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
Jiang, L., Wang, Z., Liu, C., Gong, Z., Yang, Y., Kang, H., Li, Y., & Hu, G. (2017) · Oncotarget · doi:10.18632/oncotarget.21711 · Cited by 25
Caveolin‑1 enhances RANKL‑induced gastric cancer cell migration
Wang, Y., Song, Y., Che, X., Zhang, L., Wang, Q., Zhang, X., Qu, J., Li, Z., Xu, L., Zhang, Y., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6550 · Cited by 25
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1
Hong, B., Lui, V. W. Y., Hui, E. P., Lu, Y., Leung, H. S. Y., Wong, E. Y. L., Cheng, S.-H., Ng, M. H. L., Mills, G. B., & Chan, A. T. �. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.021 · Cited by 25
Mariotti, M., Castiglioni, S., & Maier, J. A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.017 · Cited by 29
Arai, R., Tsuda, M., Watanabe, T., Ose, T., Obuse, C., Maenaka, K., Minami, A., & Ohba, Y. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.028 · Cited by 27
Divergent Modulation of Src-Family Kinase Regulatory Interactions with ATP-Competitive Inhibitors
Leonard, S. E., Register, A. C., Krishnamurty, R., Brighty, G. J., & Maly, D. J. (2014) · ACS Chemical Biology · doi:10.1021/cb500371g · Cited by 25
Martin, H. L., Bedford, R., Heseltine, S. J., Tang, A. A.-S., Haza, K. Z., Rao, A., McPherson, M. J., & Tomlinson, D. C. (2018) · New Biotechnology · doi:10.1016/j.nbt.2018.02.008 · Cited by 24
Bosutinib: A Novel Second-Generation Tyrosine Kinase Inhibitor
Isfort, S., Keller-v.Amsberg, G., Schafhausen, P., Koschmieder, S., & Brümmendorf, T. H. (2014) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-54490-3_4 · Cited by 25
Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer
Li, J., Goh, E. L. K., He, J., Li, Y., Fan, Z., Yu, Z., Yuan, P., & Liu, D. (2023) · Biology · doi:10.3390/biology12050697 · Cited by 29
Zou, H., Luo, J., Guo, Y., Deng, L., Zeng, L., Pan, Y., & Li, P. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101051 · Cited by 28
Hong, J., Boo, H., Kang, J.-I., Kim, M., Yoo, E.-S., Hyun, J. W., Koh, Y., Kim, Y. H., Maeng, Y. H., Hyun, C. L., et al. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b11-00024 · Cited by 25
Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol
Herbert, K. J., & Snow, E. T. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.05.004 · Cited by 24
Phase I study of dasatinib (BMS‐354825) in Japanese patients with solid tumors
Takahashi, S., Miyazaki, M., Okamoto, I., Ito, Y., Ueda, K., Seriu, T., Nakagawa, K., & Hatake, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02041.x · Cited by 24
Hanks, S. (2009) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s6255 · Cited by 24
BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
Mei, P.-J., Bai, J., Shi, M., Liu, Q., Li, Z., Fan, Y.-C., & Zheng, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098544 · Cited by 24
RetractedCRF2 Signaling Is a Novel Regulator of Cellular Adhesion and Migration in Colorectal Cancer Cells
Ducarouge, B., Pelissier-Rota, M. A., Lainé, M. G., Cristina, N., Vachez, Y. M., Scoazec, J., Bonaz, B. L., & Jacquier‐Sarlin, M. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079335 · Cited by 24
Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer
Sørensen, K. D., Borre, M., Orntoft, T. F., Dyrskjøt, L., & Tørring, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.23136 · Cited by 24
Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer
Saini, S., Majid, S., Shahryari, V., Tabatabai, Z. L., Arora, S., Yamamura, S., Tanaka, Y., Dahiya, R., & Deng, G. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0017 · Cited by 24
Src nuclear localization and its prognostic relevance in human osteosarcoma
Urciuoli, E., Coletta, I., Rizzuto, E., Vito, R. D., Petrini, S., D'Oria, V., Pezzullo, M., Milano, G. M., Cozza, R., Locatelli, F., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26079 · Cited by 25
A novel BLK-induced tumor model
Petersen, D. L., Berthelsen, J., Willerslev-Olsen, A., Fredholm, S., Dabelsteen, S., Bonefeld, C. M., Geisler, C., & Woetmann, A. (2017) · Tumor Biology · doi:10.1177/1010428317714196 · Cited by 24
Keller, G., Schafhausen, P., & Brümmendorf, T. H. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_9 · Cited by 24
Kinase Inhibitors and Cytotoxic Drug Resistance
Grant, S., & Dent, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0001-4 · Cited by 24
Ma, J., Huang, H., Chen, S.-M., Chen, Y., Xin, X., Lin, L., Ding, J., Liu, H. S., & Meng, L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1302-4 · Cited by 23
New Structural Perspectives in G Protein-Coupled Receptor-Mediated Src Family Kinase Activation
Berndt, S., & Liebscher, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126489 · Cited by 25
Structure-based virtual screening of Src kinase inhibitors
Lee, K., Kim, J., Jeong, K., Lee, K. W., Lee, Y., Song, J. Y., Kim, M. S., Lee, G. S., & Kim, Y. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.054 · Cited by 23
Yang, J. J., Cho, L. Y., Ko, K., Shin, A., Ma, S. H., Choi, B. Y., Han, D. S., Song, K. S., Kim, Y. S., Lee, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031020 · Cited by 23
Episodic Src activation in uveal melanoma revealed by kinase activity profiling
Maat, W., el Filali, M., Mulder, A., Luyten, G. P. M., Gruis, N. A., Desjardins, L., Boender, P. J., Jager, M. J., & van der Velden, P. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605172 · Cited by 23
Pro-Metastatic Tumor–Stroma Interactions in Breast Cancer
Gangadhara, S., Barrett-Lee, P. J., Nicholson, R. I., & Hiscox, S. (2012) · Future Oncology · doi:10.2217/fon.12.134 · Cited by 23
Argiris, A., Feinstein, T., Wang, L., Yang, T., Agrawal, S., Appleman, L., Stoller, R., Grandis, J., & Egloff, A. (2011) · Investigational new drugs · doi:10.1007/s10637-011-9732-3 · Cited by 20
Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells
Knowlton, M. L., Selfors, L. M., Wrobel, C. N., Gu, T., Ballif, B. A., Gygi, S. P., Polakiewicz, R. D., & Brugge, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013587 · Cited by 23
Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma
de la Puente, P., Azab, F., Muz, B., Luderer, M. J., Arbiser, J. L., & Azab, A. K. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1099645 · Cited by 23
PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines
Nakachi, I., Helfrich, B., Spillman, M., Mickler, E. A., Olson, C., Rice, J., Coldren, C. D., Heasley, L., Geraci, M. W., & Stearman, R. S. (2016) · Clinical and Translational Science · doi:10.1111/cts.12413 · Cited by 23
Cytokinesis Failure Leading to Chromosome Instability in v-Src-Induced Oncogenesis
Nakayama, Y., Soeda, S., Ikeuchi, M., Kakae, K., & Yamaguchi, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040811 · Cited by 24
Thibault, B., & Jean-Claude, B. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0319-2 · Cited by 23
Mahé, J., de Campaigno, E. P., Chené, A., Montastruc, J., Despas, F., & Jolliet, P. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13693 · Cited by 23
Application of MM-GB/SA and WaterMap to SRC Kinase Inhibitor Potency Prediction
Kohlmann, A., Zhu, X., & Dalgarno, D. C. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200222u · Cited by 23
Chatterji, T., Varkaris, A. S., Parikh, N. U., Song, J. H., Cheng, C.-J., Schweppe, R. E., Alexander, S., Davis, J. W., Troncoso, P., Friedl, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3391 · Cited by 22
Self-citationThe Influence of SRC-Family Tyrosine Kinases on Na,K-ATPase Activity in Lens Epithelium
Bozulic, L. D., Dean, W. L., & Delamere, N. A. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0809 · Cited by 23
Antipova, T. V., Zaitsev, K. V., Oprunenko, Y. F., Zherebker, A., Rystsov, G. K., Zemskova, M. Y., Zhelifonova, V. P., Ivanushkina, N. E., & Kozlovsky, A. G. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126708 · Cited by 22
Erdoğan, M. A., Ashour, A. A., Yuca, E., Görgülü, K., & Özpolat, B. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109938 · Cited by 22
Signaling by the tyrosine kinase Yes promotes liver cancer development
Guégan, J., Lapouge, M., Voisin, L., Saba-El-Leil, M. K., Tanguay, P., Lévesque, K., Brégeon, J., Mes‐Masson, A., Lamarre, D., Haibe‐Kains, B., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abj4743 · Cited by 21
Cicero, J., Trouvilliez, S., Palma, M., Ternier, G., Decoster, L., Happernegg, E., Barois, N., Outryve, A. V., Dehouck, L., Bourette, R. P., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00463-6 · Cited by 22
Zhong, L., Fu, X., Zou, C., Yang, L., Zhou, S. W., Yang, J., Tang, Y., Cheng, C., Li, L., Xiang, R., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28944 · Cited by 22
Nourazarian, A., Pashaei‐Asl, R., Omidi, Y., & Najar, A. G. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.2235 · Cited by 22
Chatzizacharias, N. A., Giaginis, C., Zizi, D., Kouraklis, G. P., Karatzas, G., & Theocharis, S. E. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181d7abcc · Cited by 22
Liu, X., Du, L., & Feng, R. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt042 · Cited by 22
Elevated MED28 expression predicts poor outcome in women with breast cancer
Yoon, N. K., Maresh, E. L., Elshimali, Y., Li, A., Horvath, S., Seligson, D. B., Chia, D., & Goodglick, L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-335 · Cited by 22
Szalmás, A., Gyöngyösi, E., Ferenczi, A., László, B., Karosi, T., Csomor, P., Gergely, L., Veress, G., & Kónya, J. (2013) · Virology Journal · doi:10.1186/1743-422x-10-79 · Cited by 22
Song, G., Chen, L., Zhang, B., Song, Q., Yu, Y., Moore, C. D., Wang, T., Shih, I., Zhang, H., Chan, D. W., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000851 · Cited by 22
PP2 Ameliorates Renal Fibrosis by Regulating the NF‐κB/COX‐2 and PPARγ/UCP2 Pathway in Diabetic Mice
Wei, J., Deng, X., Li, Y., Li, R., Yang, Z., Li, X., Song, S., Shi, Y., Duan, H., & Wu, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7394344 · Cited by 23
Genetic unraveling of colorectal cancer
Rasool, S., Rasool, V., Naqvi, T., Ganai, B. A., & Shah, B. A. (2014) · Tumor Biology · doi:10.1007/s13277-014-1713-7 · Cited by 25
Sommer, S., Cui, Y., Brewer, G., & Fuqua, S. A. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.09.002 · Cited by 22
Kaewmeesri, P., Pocasap, P., Kukongviriyapan, V., Prawan, A., Kongpetch, S., & Senggunprai, L. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221124861 · Cited by 21
Clinical significance of Src expression and activity in human neoplasia.
Chatzizacharias, N. A., Kouraklis, G. P., Giaginis, C., & Theocharis, S. E. (2012) · PubMed · doi:10.14670/hh-27.677 · Cited by 21
Src inhibitors in suppression of papillary thyroid carcinoma growth
Henderson, Y. C., Toro–Serra, R., Chen, Y., Ryu, J., Frederick, M. J., Zhou, G., Gallick, G. E., Lai, S. Y., & Clayman, G. L. (2013) · Head & Neck · doi:10.1002/hed.23316 · Cited by 21
Self-citationEmerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer
Patel, J. C., Maughan, B. L., Agarwal, A. M., Batten, J. A., Zhang, T. Y., & Agarwal, N. (2013) · Prostate Cancer · doi:10.1155/2013/981684 · Cited by 21
Contribution of phosphoproteomics in understanding SRC signaling in normal and tumor cells
Sirvent, A., Urbach, S., & Roche, S. (2014) · PROTEOMICS · doi:10.1002/pmic.201400162 · Cited by 21
Bosutinib: a review of preclinical and clinical studies in chronic myelogenous leukemia
Rusconi, F., Piazza, R., Vagge, E., & Gambacorti-Passerini, C. B. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.882898 · Cited by 21
Keller-v.Amsberg, G., & Brümmendorf, T. H. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.84 · Cited by 22
Src and podoplanin forge a path to destruction
Krishnan, H., Miller, W. T., Blanco, F. J., & Goldberg, G. S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.07.009 · Cited by 21
c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells
Dai, Y., & Siemann, D. W. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s201320 · Cited by 21
Li, X., Wang, F., Ren, M., Du, M.-J., & Zhou, J. (2019) · BMC Ophthalmology · doi:10.1186/s12886-019-1229-4 · Cited by 21
Prognostic relevance of Src activation in stage II-III colon cancer
Martínez-Pérez, J., Lopez-Calderero, I., Saez, C., Benavent, M., Limon, M. L., Gonzalez-Exposito, R., Soldevilla, B., Riesco-Martínez, M. C., Salamanca, J., Carnero, A., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.05.025 · Cited by 20
Nelson, L. J., Wright, H. J., Dinh, N. B., Nguyen, K. D., Razorenova, O. V., & Heinemann, F. S. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.017 · Cited by 19
Tyrosine phosphorylation of lamin A by Src promotes disassembly of nuclear lamina in interphase
Chu, C., Chen, Y.-H., Chiu, W., & Chen, H. (2021) · Life Science Alliance · doi:10.26508/lsa.202101120 · Cited by 20
New insights into the Lck-NF-κB signaling pathway
Zhang, J., Wu, Y., Hu, X., & Wei, W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1120747 · Cited by 21
Sharma, R. K., Singh, S., Tiwari, R. K., Mandal, D., Olsen, C. E., Parmar, V. S., Parang, K., & Prasad, A. K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.09.057 · Cited by 20
Resequencing Analysis of the Human Tyrosine Kinase Gene Family in Pancreatic Cancer
Kubo, T., Kuroda, Y., Kokubu, A., Hosoda, F., Arai, Y., Hiraoka, N., Hirohashi, S., & Shibata, T. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181b8feb0 · Cited by 20
Randhawa, V., & Bagler, G. (2012) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0160 · Cited by 20
Metadata
- Authors
- Summy, J. M., & Gallick, G. E.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Gallick, Gary E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2003-12
- Volume
- 22
- Issue
- 4
- Pages
- 337-358
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1589166971
- Cited by
- 827
- References
- 171
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 17 · 2023: 17 · 2022: 26 · 2021: 27 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 64 · 2013: 55 · 2012: 49
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Cancer and Metastasis Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca065527-07)
- National Cancer Institute (U54CA090810, 2 R01 CA65527)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src family kinases, Src kinase, non-receptor tyrosine kinase, tumor progression, metastasis, constitutive kinase activation, v-Src, malignant transformation, cell migration and invasion, angiogenesis, apoptosis resistance, cancer therapeutics, colorectal cancer, breast cancer, melanoma, lung cancer
- MeSH terms
- Enzyme Activation, Humans, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Disease Progression, src-Family Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review